The Bay Setting Approach to Therapeutics - What's Next?

Soh: I want to touch on this deal that you did, i think, within the last year. They had some delivery technology and your structure to deal in an unusual way. Soh: We can do things in a cell that are clearly different than what anyone else can do with any tools. And so as soon as you've done that, you've created a lot of value becauset, it's self evident that this is important. But now, at the time of your ipo, you're pre clinical still pre clinical with all these programmes. Ah, many of us have been treated with them now. You know, hundreds of millions of people around the world will be